Abstract
Abstract35 Pyrimidin‐Nucleosidanaloga (I) werden in 21 ‐ 98%iger Ausbeute dargestellt und als WachstumJnhibitoren von Sar‐ coma 180‐Zellen, HerpesSimplex Virus (Typ 1) und Streptococcus faecium getestet.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
